HEMEX HEALTH INC
Point-of-care blood diagnostic device for chronic disease diagnosis and monitoring
- Sector
- Medtech
- Headquarters
- Portland, OR
- Founded
- 2016
- Latest Form D
- $930K, Mar 2018
- Total capital
- $16.3M
- Federal grants
- $15.3M
- 21 awards · 2017–2025
- Rank in peer group#193 of 538
- Private capital raised
- $1M
- 3 Form D · last Mar 2018
- 103 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 17
- 23 pending · first 2019
- Rank in peer group#30 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias$991K
- Federal grantHealth and Human S · Phase I · Using an Inclined Plane System to Triage TBI Patients$332K
- Federal grantHealth and Human S · Phase II · Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias$995K
- Federal grantHealth and Human S · Phase I · RHODA: Rapid Hemoglobin-Oxygen Dissociation Assay$296K
- Federal grantHealth and Human S · Phase II · Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing$865K
- Federal grantHealth and Human S · Phase II · Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias$1M
- Federal grantHealth and Human S · Phase II · Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias$1M
- Private capital raisedForm D · SEC · 3rd filing$930K
- Offering registeredForm D · SEC · 2nd filing$27K
- Private capital raisedForm D · SEC · 1st filing$100K
Show 13 earlier federal awards
- Federal grantHealth and Human S · Phase II · Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing$865K
- Federal grantHealth and Human S · Phase II · Rapid, Point of Care Diagnostic for Malaria, highly sensitive for P. vivax, with species differentiation$828K
- Federal grantHealth and Human S · Phase I · Using Multi-Spectral Imaging with Microchip Electrophoresis to Accurately Screen Newborns for Sickle Cell Disease$257K
- Federal grantHealth and Human S · Phase II · Rapid, Point of Care Diagnostic for Malaria, highly sensitive for P. vivax, with species differentiation$840K
- Federal grantHealth and Human S · Phase II · Rapid, Point of Care Diagnostic for Malaria, highly sensitive for P. vivax, with species differentiation$1.7M
- Federal grantHealth and Human S · Phase I · Portable, affordable, quantitative microchip electrophoresis system for integrated anemia and hemoglobin variant testing$225K
- Federal grantHealth and Human S · Phase II · HLS-Affordable, quantitative microchip-electrophoresis for sickle cell disease screening$750K
- Federal grantHealth and Human S · Phase II · HLS-Affordable, quantitative microchip-electrophoresis for sickle cell disease screening$750K
- Federal grantHealth and Human S · Phase II · HLS-Affordable, quantitative microchip-electrophoresis for sickle cell disease screening$225K
- Federal grantHealth and Human S · Phase I · Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing$225K
- Federal grantHealth and Human S · Phase II · HLS-Highly-Sensitive, One-minute, Portable Diagnostic for Malaria Elimination$746K
- Federal grantHealth and Human S · Phase II · HLS-Highly-Sensitive, One-minute, Portable Diagnostic for Malaria Elimination$1.5M
- Federal grantHealth and Human S · Phase II · HLS-Highly-Sensitive, One-minute, Portable Diagnostic for Malaria Elimination$741K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#193 · top 36%
- Granted patents#30 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Peter White GalenResearcherExecutive Officer, Director, PromoterLinked by 3 patents · $15.3M in grants as PI
- Annette White MuleeDirector, PromoterNamed in SEC Form D filings
- Mohan UttarwarDirectorNamed in SEC Form D filings
- Patricia SeminarioExecutive Officer, DirectorNamed in SEC Form D filings
- Prakash White AgarwalDirectorNamed in SEC Form D filings
- Susan MorgenszternDirectorNamed in SEC Form D filings
What it has protected
USPTO · 17 granted of 40- GrantedUsing Electrophoresis For Disease Detection Based On Controlled Molecular ChargeUSPTOUS 12,736,500
- GrantedDiagnostics Systems And MethodsUSPTOUS 12,656,310
- GrantedCombination Of Reflective And Transmissive Sensors With Characteristic Wavelengths For Physiological MonitoringUSPTOUS 12,616,399
Show all 40 patent records
- Using Electrophoresis For Disease Detection Based On Controlled Molecular ChargeSep 15, 2026 · US 12,736,500Granted
- Diagnostics Systems And MethodsJun 16, 2026 · US 12,656,310Granted
- Combination Of Reflective And Transmissive Sensors With Characteristic Wavelengths For Physiological MonitoringMay 5, 2026 · US 12,616,399Granted
- Diagnostic CartridgeApr 30, 2026 · Application 18681458Pending
- Enhanced Imaging & Quantification Techniques For Lateral Flow AssaysNov 6, 2025 · Application 18860837Pending
- Malaria Species DetectionJul 29, 2025 · US 12,372,512Granted
- Using Electrophoresis For Disease Detection Based On Controlled Molecular ChargeJul 18, 2024 · Application 18618784Pending
- Improved Detection Of Hemoglobin And Other Compounds By ElectrophoresisJun 20, 2024 · Application 18555955Pending
- Using Electrophoresis For Disease Detection Based On Controlled Molecular ChargeApr 30, 2024 · US 11,971,384Granted
- Diagnostics Systems And MethodsOct 5, 2023 · Application 18330090Pending
- Diagnostics Systems And MethodsAug 29, 2023 · US 11,740,203Granted
- Inducing Hypoxia To Monitor One Or More Patient Conditions Using A Medical Device SystemAug 3, 2023 · Application 18151919Pending
- Diagnostics Systems And MethodsJul 18, 2023 · US 11,701,039Granted
- Diagnostics Systems And MethodsMay 23, 2023 · US 11,656,220Granted
- Diagnostic CartridgeNov 1, 2022 · US D,968,641Granted
- Diagnostic Testing Devices, Systems And MethodsMay 12, 2022 · Application 17602182Pending
- Using Electrophoresis For Disease Detection Based On Controlled Molecular ChargeFeb 22, 2022 · US 11,255,815Granted
- Diagnostic Systems And MethodsNov 4, 2021 · Application 17286384Pending
- External SonicationSep 23, 2021 · Application 17342343Pending
- Malaria Species DetectionJul 13, 2021 · US 11,061,014Granted
- External SonicationJul 6, 2021 · US 11,053,473Granted
- Diagnostic CartridgeNov 10, 2020 · US D,901,711Granted
- Diagnostics Systems And MethodsSep 8, 2020 · US 10,768,166Granted
- Diagnostic CartridgeJul 14, 2020 · US D,890,360Granted
- Diagnostics Systems And MethodsAug 13, 2019 · US 10,375,909Granted
- Diagnostics Systems And MethodsJul 16, 2019 · US 10,349,589Granted
- Detection Of Hemoglobin And Other Compounds By ElectrophoresisApplication 63179118Pending
- Diagnostic Cartridge Tray Assemblies & Methods Of Using Diagnostic Cartridge Tray Assemblies In Diagnostic TestsApplication PCTUS2025053267Pending
- Using Electrophoresis For Disease Detection Based On Controlled Molecular ChargeApplication PCTUS2021027566Pending
- Using Electrophoresis For Disease Detection Based On Controlled Molecular ChargeApplication PCTUS2024026884Pending
- Optically-readable Encoded Health DataApplication 63668611Pending
- Electrophoresis One-step CartridgeApplication 63713994Pending
- Malaria Species DetectionApplication PCTUS2020039675Pending
- Optically-readable Encoded Health DataApplication PCTUS2025036677Pending
- Improved Detection Of Hemoglobin And Other Compounds By ElectrophoresisApplication PCTUS2022071903Pending
- Diagnostics Systems And MethodsApplication PCTUS2020039651Pending
- Infectious Disease Detection & DiagnosticsApplication 63010570Pending
- Diagnostic Testing Devices, Systems And MethodsApplication PCTUS2020027810Pending
- Detection Of Hemoglobin And Other Compounds By ElectrophoresisApplication 62987237Pending
- Diagnostic Systems And MethodsApplication PCTUS2019056832Pending
Related companies, and why
- REBISCAN, LLCSimilar federal contract value in Medtech · null in contracts
- Applied Research and PhotonicsSimilar federal contract value in Medtech · null in contracts
- CHRONO THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
- Spinethera, Inc.Similar federal contract value in Medtech · null in contracts
- IKONISYS INCSimilar federal contract value in Medtech · null in contracts
- Avails Medical, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .